Close Menu

NEW YORK – Chinese cancer genomic profiling firm Genetron Health said on Tuesday that its Detection Kit for Novel Coronavirus (SARS-CoV-2) RNA (PCR-Fluorescence Probing) has received the CE mark.

The company also said that three of its clinical laboratories have passed a COVID-19 external quality assessment by China's National Center for Clinical Laboratories (NCCL).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.